Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Aurora Kinase A Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 AMG-900
  • 1.3.3 Danusertib
  • 1.3.4 ENMD-2076
  • 1.3.5 Ilorasertib
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Aurora Kinase A Market Share by Application (2019-2025)
  • 1.4.2 Ovarian Cancer
  • 1.4.3 Anaplastic Large Cell Lymphoma
  • 1.4.4 Brain Tumor
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Aurora Kinase A Market Size
  • 2.1.1 Global Aurora Kinase A Revenue 2014-2025
  • 2.1.2 Global Aurora Kinase A Sales 2014-2025
• 2.2 Aurora Kinase A Growth Rate by Regions
  • 2.2.1 Global Aurora Kinase A Sales by Regions 2014-2019
  • 2.2.2 Global Aurora Kinase A Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Aurora Kinase A Sales by Manufacturers
  • 3.1.1 Aurora Kinase A Sales by Manufacturers 2014-2019
  • 3.1.2 Aurora Kinase A Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Aurora Kinase A Revenue by Manufacturers (2014-2019)
  • 3.2.2 Aurora Kinase A Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Aurora Kinase A Market Concentration Ratio (CR5 and HHI)
• 3.3 Aurora Kinase A Price by Manufacturers
• 3.4 Key Manufacturers Aurora Kinase A Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Aurora Kinase A Market
• 3.6 Key Manufacturers Aurora Kinase A Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 AMG-900 Sales and Revenue (2014-2019)
  • 4.1.2 Danusertib Sales and Revenue (2014-2019)
  • 4.1.3 ENMD-2076 Sales and Revenue (2014-2019)
  • 4.1.4 Ilorasertib Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Aurora Kinase A Sales Market Share by Type
• 4.3 Global Aurora Kinase A Revenue Market Share by Type
• 4.4 Aurora Kinase A Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Aurora Kinase A Sales by Application

6 United States

• 6.1 United States Aurora Kinase A Breakdown Data by Company
• 6.2 United States Aurora Kinase A Breakdown Data by Type
• 6.3 United States Aurora Kinase A Breakdown Data by Application

7 European Union

• 7.1 European Union Aurora Kinase A Breakdown Data by Company
• 7.2 European Union Aurora Kinase A Breakdown Data by Type
• 7.3 European Union Aurora Kinase A Breakdown Data by Application

8 China

• 8.1 China Aurora Kinase A Breakdown Data by Company
• 8.2 China Aurora Kinase A Breakdown Data by Type
• 8.3 China Aurora Kinase A Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Aurora Kinase A Breakdown Data by Company
• 9.2 Rest of World Aurora Kinase A Breakdown Data by Type
• 9.3 Rest of World Aurora Kinase A Breakdown Data by Application
• 9.4 Rest of World Aurora Kinase A Breakdown Data by Countries
  • 9.4.1 Rest of World Aurora Kinase A Sales by Countries
  • 9.4.2 Rest of World Aurora Kinase A Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AbbVie Inc.
  • 10.1.1 AbbVie Inc. Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.1.4 Aurora Kinase A Product Introduction
  • 10.1.5 AbbVie Inc. Recent Development
• 10.2 Amgen Inc.
  • 10.2.1 Amgen Inc. Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.2.4 Aurora Kinase A Product Introduction
  • 10.2.5 Amgen Inc. Recent Development
• 10.3 Astex Pharmaceuticals, Inc.
  • 10.3.1 Astex Pharmaceuticals, Inc. Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.3.4 Aurora Kinase A Product Introduction
  • 10.3.5 Astex Pharmaceuticals, Inc. Recent Development
• 10.4 CASI Pharmaceuticals Inc.
  • 10.4.1 CASI Pharmaceuticals Inc. Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.4.4 Aurora Kinase A Product Introduction
  • 10.4.5 CASI Pharmaceuticals Inc. Recent Development
• 10.5 Merck & Co., Inc.
  • 10.5.1 Merck & Co., Inc. Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.5.4 Aurora Kinase A Product Introduction
  • 10.5.5 Merck & Co., Inc. Recent Development
• 10.6 Millennium Pharmaceuticals, Inc.
  • 10.6.1 Millennium Pharmaceuticals, Inc. Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.6.4 Aurora Kinase A Product Introduction
  • 10.6.5 Millennium Pharmaceuticals, Inc. Recent Development
• 10.7 Sanofi
  • 10.7.1 Sanofi Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.7.4 Aurora Kinase A Product Introduction
  • 10.7.5 Sanofi Recent Development
• 10.8 Sareum Holdings Plc
  • 10.8.1 Sareum Holdings Plc Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.8.4 Aurora Kinase A Product Introduction
  • 10.8.5 Sareum Holdings Plc Recent Development
• 10.9 Sigma-Tau S.p.A.
  • 10.9.1 Sigma-Tau S.p.A. Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.9.4 Aurora Kinase A Product Introduction
  • 10.9.5 Sigma-Tau S.p.A. Recent Development
• 10.10 Taiho Pharmaceutical Co., Ltd.
  • 10.10.1 Taiho Pharmaceutical Co., Ltd. Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Aurora Kinase A
  • 10.10.4 Aurora Kinase A Product Introduction
  • 10.10.5 Taiho Pharmaceutical Co., Ltd. Recent Development
• 10.11 Vertex Pharmaceuticals Incorporated
• 10.12 Vichem Chemie Research Ltd.

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Aurora Kinase A Sales Channels
  • 11.2.2 Aurora Kinase A Distributors
• 11.3 Aurora Kinase A Customers

12 Market Forecast

• 12.1 Global Aurora Kinase A Sales and Revenue Forecast 2019-2025
• 12.2 Global Aurora Kinase A Sales Forecast by Type
• 12.3 Global Aurora Kinase A Sales Forecast by Application
• 12.4 Aurora Kinase A Forecast by Regions
  • 12.4.1 Global Aurora Kinase A Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Aurora Kinase A Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Aurora Kinase A is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Aurora Kinase A.

This report studies the global market size of Aurora Kinase A, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Aurora Kinase A sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.

Market Segment by Product Type
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others

Market Segment by Application
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Aurora Kinase A status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Aurora Kinase A manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Aurora Kinase A are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025